Abstract
Avian H5N1 influenza viruses first emerged as members of a new human influenza A subtype in Hong Kong in 1997 and there are continuing concerns that members of the subtype will be the cause of the next pandemic. Human-tohuman transmission is rare, but mortality rates associated with avian-to-human transmission are significantly higher than for current human epidemic strains. Severe human H5N1 infections are associated with severe viral pneumonia, diffuse alveolar damage and reactive hemophagocytic syndrome (RHS). A characteristic of RHS, and one of the key determinants of H5N1-mediated pathology, is dysfunctional cytokine production resulting in a cytokine storm. Factors contributing to cytokine dysregulation include viral load, apoptosis and the intrinsic properties of H5N1 virus strains. Here, we review the cytokine response to influenza and try to address the relationship between hypercytokinemia and severe H5N1 pathology.
Keywords: Pathogenic, H5N1, cytokine, storm, reactive, hematophagocytic, syndrome
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: The Induction of Proinflammatory Cytokines in Response to Avian Influenza H5N1 Infections and their Role in Pathogenesis and the Enhancement of Virulence
Volume: 7 Issue: 2
Author(s): Mark D. Wareing and Gregory A. Tannock
Affiliation:
Keywords: Pathogenic, H5N1, cytokine, storm, reactive, hematophagocytic, syndrome
Abstract: Avian H5N1 influenza viruses first emerged as members of a new human influenza A subtype in Hong Kong in 1997 and there are continuing concerns that members of the subtype will be the cause of the next pandemic. Human-tohuman transmission is rare, but mortality rates associated with avian-to-human transmission are significantly higher than for current human epidemic strains. Severe human H5N1 infections are associated with severe viral pneumonia, diffuse alveolar damage and reactive hemophagocytic syndrome (RHS). A characteristic of RHS, and one of the key determinants of H5N1-mediated pathology, is dysfunctional cytokine production resulting in a cytokine storm. Factors contributing to cytokine dysregulation include viral load, apoptosis and the intrinsic properties of H5N1 virus strains. Here, we review the cytokine response to influenza and try to address the relationship between hypercytokinemia and severe H5N1 pathology.
Export Options
About this article
Cite this article as:
Wareing D. Mark and Tannock A. Gregory, The Induction of Proinflammatory Cytokines in Response to Avian Influenza H5N1 Infections and their Role in Pathogenesis and the Enhancement of Virulence, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2008; 7 (2) . https://dx.doi.org/10.2174/187152308784533131
DOI https://dx.doi.org/10.2174/187152308784533131 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future
Current Cancer Drug Targets Target-oriented Mechanisms of Novel Herbal Therapeutics in the Chemotherapy of Gastrointestinal Cancer and Inflammation
Current Pharmaceutical Design The Importance of Precise Documentation of Vaccination by Physicians and Vaccine Providers
Current Drug Safety Minocycline and Doxycycline: More Than Antibiotics
Current Molecular Pharmacology An Overview of Acute Flaccid Myelitis
CNS & Neurological Disorders - Drug Targets A Brief Overview of Tyrosine Hydroxylase and α-Synuclein in the Parkinsonian Brain
CNS & Neurological Disorders - Drug Targets Potential Therapeutic Application of Chondroitin Sulfate/Dermatan Sulfate
Current Drug Discovery Technologies Application of Alphaviral Vectors for Immunomodulation in Cancer Therapy
Current Pharmaceutical Design The Immunoproteasome: An Emerging Therapeutic Target
Current Topics in Medicinal Chemistry Oseltamivir in Neonates, Infants and Young Children: A Focus on Clinical Pharmacology
Infectious Disorders - Drug Targets The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Overview of Immunotherapy in Alzheimer’s Disease (AD) and Mechanisms of IVIG Neuroprotection in Preclinical Models of AD)
Current Alzheimer Research Commentary: (Research Highlights Inflammation, Demyelination and Neurodegeneration: Risky Buddies in Multiple Sclerosis)
CNS & Neurological Disorders - Drug Targets Risk Factors for Different Grades of Lower Respiratory Tract Infections in Children Under Five Years Old with Measles: Based on Chest Radiography
Current Medical Imaging PI3K-Akt Signaling and Viral Infection
Recent Patents on Biotechnology Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Diffusion Tensor Imaging to Determine Effects of Antidementive Treatment on Cerebral Structural Connectivity in Alzheimer’s Disease
Current Pharmaceutical Design Evaluating a Child with Partial Developmental Delay (ParDD), Global Developmental Delay (GDD)/Mental Retardation (MR): Clinical Expertise Based or Evidence-Based?
Current Pediatric Reviews Enterovirus D-68 Molecular Virology, Epidemiology, and Treatment: an Update and Way Forward
Infectious Disorders - Drug Targets Dementia Etiologies and Remedies in Traditional Persian Medicine; A Review of Medicinal Plants and Phytochemistry
Current Drug Metabolism